Canadian men's hormone health and low testosterone treatment provider is No. 1 in British Columbia and No. 4 in Canada for three-year revenue growth

BURNABY, BC, Nov. 13, 2026 /CNW/ -- UPGUYS Health Inc., the Burnaby-based men's hormone health platform best known for low testosterone treatment, has ranked No. 1 on the 2026 Report on Business magazine's ranking of British Columbia's Top Growing Companies. British Columbia's Top Growing Companies is an editorial ranking launched in 2025 within Report on Business magazine's Canada's Top Growing Companies portfolio, recognizing industry leaders in select provinces. In 2026, the provinces recognized by the ranking are Alberta, British Columbia, Ontario and Quebec.

To qualify for this program, companies voluntarily completed an in-depth application process and fulfilled targeted revenue requirements. In total, 52 companies earned a spot on this year's ranking.

Recognizing growth leaders in British Columbia

Listings within the Top Growing Companies program rank Canadian companies on three-year revenue growth. UPGUYS Health Inc. earned its spot with three-year growth of 5,308%.

UPGUYS helps men in Canada check their testosterone and other hormone levels and, when levels are low, get physician-led care to treat and optimize them. Its main service is low testosterone treatment, also called testosterone replacement therapy (TRT), available in Alberta, British Columbia, Manitoba, Ontario, Quebec and Saskatchewan. UPGUYS also treats erectile dysfunction, hair loss and premature ejaculation, as part of its focus on men's health and longevity.

Care starts with an online symptom review and morning blood tests at a local lab. A Canadian-licensed practitioner reviews the results and decides whether treatment is appropriate, and follow-up blood work is part of ongoing care. Medication, when prescribed, is dispensed by the company's two licensed Canadian pharmacies, in Burnaby, BC and Toronto, ON. UPGUYS has served more than 200,000 Canadian patients.

The B.C. ranking comes weeks after UPGUYS placed No. 4 on The Globe and Mail's 2026 Canada's Top Growing Companies, making it No. 1 in British Columbia and No. 4 in Canada this year.

"Being ranked No. 1 in British Columbia means a lot to us, because this is where UPGUYS started. Low testosterone affects many Canadian men who never get properly tested. We built UPGUYS in Burnaby to give them a clear, physician-led way to check their hormone levels and, when it's needed, get treatment such as TRT. More than 200,000 patients across Canada have now trusted us with their care," said Mat Rezaei, Co-Founder and CEO of UPGUYS Health Inc.

"Our growth comes from doing the basics properly for every patient: a symptom review, morning blood tests, a licensed practitioner's decision and ongoing follow-up. We're proud to keep building that care, and our team, here in B.C.," said Ramin Behzadi, Co-Founder and CSO of UPGUYS Health Inc.

The full list of 2026 winners along with editorial coverage is published online on The Globe and Mail Report on Business magazine website

"While our annual ranking of Canada's Top Growing Companies celebrates the innovation and resilience of businesses nationwide, this ranking takes a specifically regional lens – bringing new energy, focus, and perspective to the diverse range of businesses and success stories across the country. We're excited to showcase what success looks like from coast to coast," says Garth Thomas, Managing Director of The Globe and Mail, Business and Financial Products.

About UPGUYS Health
UPGUYS is a Canadian men's longevity and hormone optimization platform with pharmacy services. Founded in 2019 and headquartered in Burnaby, British Columbia, UPGUYS serves patients in 12 Canadian provinces and territories through a network of Canadian-licensed practitioners and two licensed Canadian pharmacies, in Burnaby, BC and Toronto, ON. UPGUYS has served more than 200,000 Canadian patients. UPGUYS provides low testosterone treatment, available in Alberta, British Columbia, Manitoba, Ontario, Quebec and Saskatchewan, and related men's health care. Low testosterone treatment, sometimes called testosterone replacement therapy (TRT), begins with a symptom review and morning blood tests; a licensed practitioner determines whether treatment is appropriate for each patient. UPGUYS was ranked No. 4 on The Globe and Mail's 2026 Canada's Top Growing Companies list, with three-year revenue growth of 5,308%, its second consecutive year in the top 10, and No. 1 on The Globe and Mail's 2026 ranking of British Columbia's Top Growing Companies. Its pharmacies are licensed by the College of Pharmacists of British Columbia (licence 38287) and accredited by the Ontario College of Pharmacists (accreditation 309322), and the company is LegitScript-certified. Learn more at upguys.com. Newsroom: upguys.com/news.

UPGUYS is part of UPGUYS Health Inc., whose brand portfolio includes UPGUYS (men's health), Everbliss (women's health), UPRX (licensed pharmacies), Upclinic (telehealth), and Uphealth Pharma (pharmaceutical contract manufacturing).

About The Globe and Mail
The Globe and Mail is Canada's foremost news media company, leading the national discussion and causing policy change through brave and independent journalism since 1844. With our award-winning coverage of business, politics and national affairs, The Globe and Mail newspaper reaches 6.1 million readers every week in our print or digital formats, and Report on Business magazine reaches 2.7 million readers in print and digital every issue. Our investment in innovative data science means that as the world continues to change, so does The Globe. The Globe and Mail is owned by Woodbridge, the investment arm of the Thomson family.

SOURCE UPGUYS Health Inc